Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

FWBI First Wave BioPharma

Watchlist
5.430
-0.250-4.40%
Close  01/27 16:00 ET
5.4300.0000.00%
Post Mkt Price 01/27 19:47 ET
High
5.820
Open
5.600
Turnover
2.37M
Low
5.200
Pre Close
5.680
Volume
431.61K
Market Cap
5.40M
P/E(TTM)
Loss
52wk High
348.600
Shares
995.00K
P/E(Static)
Loss
52wk Low
3.012
Float Cap
5.36M
Bid/Ask %
-50.00%
Historical High
11760.000
Shs Float
986.73K
Volume Ratio
0.11
Historical Low
3.010
Dividend TTM
--
Div Yield TTM
--
P/B
-2.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
43.74%
Amplitude
10.92%
Avg Price
5.485
Lot Size
1
Float Cap
5.36M
Bid/Ask %
-50.00%
Historical High
11760.000
Shs Float
986.73K
Volume Ratio
0.11
Historical Low
3.010
Dividend TTM
--
P/B
-2.37
Dividend LFY
--
Turnover Ratio
43.74%
Amplitude
10.92%
Avg Price
5.485
Lot Size
1
Price Forecast

News

Comment

Company Overview More
First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm involves in therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD,FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
CEO: Mr. James Sapirstein
Market: NASDAQ
Listing Date: 10/11/2016
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist